Robert G. Finizio's Insider Trades & SAST Disclosures
Robert G. Finizio's most recent trade in ZyVersa Therapeutics Inc was a trade of 132 Stock Options done . Disclosure was reported to the exchange on May 24, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert G. Finizio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ZyVersa Therapeutics Inc | Finizio G. Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 132 | 132 | - | - | Stock Options | |
| ZyVersa Therapeutics Inc | Robert G. Finizio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 29,781 | 29,781 | - | - | Stock Options (right to buy) | |
| ZyVersa Therapeutics Inc | Robert G. Finizio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 19,854 | 19,854 | - | - | Stock Options (right to buy) | |
| ZyVersa Therapeutics Inc | Robert G. Finizio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 9,927 | 9,927 | - | - | Stock Options (right to buy) | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 1,493,333 | 1,493,333 | - | - | Performance Stock Units | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 746,667 | 746,667 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 158,334 | 316,666 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 158,334 | 18,059,334 (6%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 10 May 2021 | 67,697 | 17,991,637 (6%) | 0% | 1.0 | 70,405 | Common Stock |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 350,000 | 18,201,000 (6%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 300,000 | 17,901,000 (6%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | 04 Mar 2021 | 179,000 | 18,580,964 (6%) | 0% | 0.2 | 43,748 | Common Stock | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | 04 Mar 2021 | 179,000 | 0 | - | - | Warrants (right to buy) | ||
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 04 Mar 2021 | 29,964 | 18,551,000 (6%) | 0% | 1.5 | 43,747 | Common Stock |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 1 | 1 | - | - | Restricted Stock Unit | |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.47 per share. | 09 Jun 2020 | 25,000 | 18,401,964 (6%) | 0% | 1.5 | 36,750 | Common Stock |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 09 Jun 2020 | 21,000 | 18,376,964 (6%) | 0% | 1.4 | 29,610 | Common Stock |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 05 Jun 2020 | 20,000 | 18,355,964 (6%) | 0% | 1.2 | 23,000 | Common Stock |
| TherapeuticsMD Inc | Robert G. Finizio | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 05 Jun 2020 | 10,000 | 18,335,964 (6%) | 0% | 1.2 | 11,600 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges